Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged inAllNewsSportCultureLifestyleAn erectile dysfunction drug, tadalafil, has been linked to an increased risk of glaucoma, a leading cause of blindness, according to a new study. Researchers in Taiwan found that men taking tadalafil were 22 per cent more likely to develop glaucoma and 33 per cent more likely to develop primary open angle glaucoma. The study, published in the British Journal of Ophthalmology, suggests that long-term users of tadalafil should have their eye health monitored, particularly those with pre-existing conditions or a family history of glaucoma. Tadalafil, which also treats enlarged prostate symptoms, works by relaxing muscles and increasing blood flow but has previously been associated with various eye health issues. While the observational study does not establish a direct cause-and-effect, experts stress the importance of regular eye tests as glaucoma often develops without symptoms. In fullErectile dysfunction drug may raise glaucoma risk, researchers warnMore bulletinsThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Men taking tadalafil could be increasing their risk of glaucoma by a third

Researchers say patients taking tadalafil - commonly prescribed under the brand name Cialis - may be up to 33 per cent more likely to develop glaucoma.